Thursday, October 1, 2026 300 stories · 3121 outlet reports compared

US indicts two Indian nationals over alleged counterfeit Ozempic smuggling scheme

A federal grand jury in Florida's Middle District indicted two Indian citizens accused of smuggling counterfeit Ozempic obtained in China and selling it to US distributors at discounted prices, the Justice Department announced.

By The Lumen desk · Compared by the Lumen AI engine · Oct 1, 2026 · 1 min read
Share Save
From The Lumen
Your brand, here.Reach readers who see every side of the story.Advertise with us
What we know
1 A federal grand jury in the Middle District of Florida indicted two Indian nationals over an alleged counterfeit Ozempic scheme.
2 The suspects allegedly obtained counterfeit Ozempic in China and sold it to U.S. distributors at discounted prices.
3 The Justice Department announced the indictment.
4 The case comes amid record use of GLP-1 weight-loss drugs like Ozempic among U.S. adults, according to CNBC.

Two Indian nationals have been indicted by a federal grand jury in the Middle District of Florida in connection with an alleged scheme to smuggle counterfeit versions of the weight-loss drug Ozempic into the United States, according to the Justice Department.

From The Lumen · story continues below
Our mission
One story. Every side. You decide what to make of it.
Join free

The suspects allegedly obtained the counterfeit Ozempic in China and sold it to U.S. distributors at discounted prices, according to multiple outlets.

CNBC noted the indictment comes as use of GLP-1 drugs such as Novo Nordisk's Ozempic for weight loss has reached new highs among U.S. adults.

Details on the specific charges, the identities of the two individuals, and the scale of the alleged scheme were not fully specified in available reporting.

How each side covered it

Left

1 outlet
  • Reported two Indian citizens were indicted in connection with the counterfeit Ozempic scheme.
  • Noted the drugs were smuggled and sold to U.S. distributors at discounted prices.

“Two Indian citizens are accused of smuggling counterfeit Ozempic to distributors in the U.S. at discounted prices.” — CBS News

Center

3 outlets
  • Reported the counterfeit Ozempic was allegedly obtained in China before being sold to U.S. distributors.
  • CNBC linked the case to record-high use of GLP-1 weight-loss drugs among U.S. adults.
  • Multiple center outlets confirmed the indictment of two Indian nationals.

“The criminal indictment in Florida comes as the use of GLP-1 drugs such as Novo's Ozempic for weight loss has hit new highs among U.S. adults.” — CNBC

Right

2 outlets
  • Emphasized that a federal grand jury in the Middle District of Florida issued the indictment.
  • Described the alleged scheme as transnational in nature, per the Justice Department's announcement.

“A federal grand jury in the Middle District of Florida has indicted two Indian nationals on charges tied to an alleged transnational scheme to sell counterfeit Ozempic to U.S. distributors.” — The Washington Times

Questions readers ask

What happened with the counterfeit Ozempic case?

A federal grand jury in the Middle District of Florida indicted two Indian nationals accused of smuggling counterfeit Ozempic obtained in China and selling it to U.S. distributors at discounted prices, according to the Justice Department.

Where were the counterfeit drugs obtained?

The suspects allegedly obtained the counterfeit Ozempic in China before selling it to distributors in the United States, according to multiple outlets.

Why does this case matter?

CNBC reported that the indictment comes as use of GLP-1 weight-loss drugs such as Ozempic has reached new highs among U.S. adults, raising concerns about counterfeit versions entering the supply chain.

Who brought the charges?

The U.S. Department of Justice announced the indictment following action by a federal grand jury in Florida's Middle District.

Sources · 6 outlet reports

Advertise with The Lumen
Put your brand in front of readers who read to the end
Talk to us about placements. advertise@thelumen.io

More in Business

All Business ›

Apple Pay launches in India in partnership with Axis Bank

Sept 30, 2026 · Blindspot: Right

Paramount streaming chief Cindy Holland to exit ahead of Warner Bros. Discovery merger

Sept 30, 2026 · Blindspot: Right

NBA nears decision on ownership for new Las Vegas expansion team

Sept 30, 2026 · Not enough coverage